Skip to content
OpenCapital
Get started

Aurinia Pharmaceuticals AUPH Change in Prepaids

Change in Prepaids at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$2.69M-168%

Other financials

Income statement

See full
Revenue$77.7M+24.4%
Gross profit$71.2M+32.1%
Operating income$41.4M+89.6%
Net income$34.4M+47.2%
EPS (diluted)$0.25+56.3%

Balance sheet

See full
Cash & equivalents$41.0M-38.3%
Total debt$85.2M-7.9%
Total equity$567.6M+62.1%
Total assets$724.0M+43.4%

Cash flow

See full
Operating cash flow$32.6M+2,405%

Valuation

See full
Market cap$2.39B+78.5%

Profitability

See full
Gross margin89.7%+1.5pp
Operating margin41.7%+29.4pp
Net margin100%+83.9pp

Returns & leverage

See full
Return on equity65%+53.8pp
Debt / equity0.2×-0.1×
Current ratio5.5×-0.4×

Where this comes from

Reported directly by Aurinia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aurinia Pharmaceuticals's change in prepaids.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Aurinia Pharmaceuticals's change in prepaids?
Aurinia Pharmaceuticals (AUPH) reported change in prepaids of -$950K in Q1 2026.
How has Aurinia Pharmaceuticals's change in prepaids changed year-over-year?
Aurinia Pharmaceuticals's change in prepaids increased by 84.3% year-over-year, from -$6.03M to -$950K.
What does change in prepaids mean?
This measures the net change in cash outflows for goods or services that will be consumed in future periods, such as insurance premiums or software subscriptions. It reflects the company's working capital management and timing of payments for upcoming operational needs. A significant increase may indicate higher future operational commitments or changes in procurement cycles.